Wellnex Life Limited (Wellnex, WNX or Company) (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently published a key ASX announcement.
Wellnex Life Limited (ASX) ("Wellnex Life" or the "Company"), is pleased to announce announce that it has finalised a placement of $500,000 with a strategic investor at a 133% premium to the current share price at $1.40 per share ($0.605 – closing price 18 November 2024).
Announcement Highlights
1. Wellnex Life has completed a placement to strategic investor at a 133% premium to the current share price at $1.40 per share
2. Placement validated the future plans of the business and growth opportunities
3. Wellnex Life experiencing significant growth across all business units in FY25 primarily in the high value brand business
4. Wellnex Life expects to continue to see substantial growth for the remainder of FY25
A huge congratulations to George Karafotias, Zack Bozinovski, the board and the team at WNX for reaching this milestone.
Read the full Wellnex Life Company Update here.
To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.
